Cátia Proenca, PhD
Catia Proenca an Associate Director at Alira Health. Previously she was an Associate Director at Wellmera, working on real-world evidence and market access projects. Catia is involved in the management and design of real-world evidence studies, from prospective observational research to cross-sectional studies, including patient and caregiver-reported outcomes. She contributes to the development of market access strategies aimed at communicating the value of medicines to key stakeholders, preparing a positive environment to support the uptake of products by identifying gaps and advising on evidence generation, and conducting marketplace analyses to understand the competitive environment.
Catia has over thirteen years’ experience in both industry and academic research. Prior to joining Wellmera Catia worked in Real-World Evidence Cardio-Metabolic franchise at Novartis Global (Basel, Switzerland) where she was involved in the design and publication of non-interventional observational studies. Prior to that, Catia worked at the Novartis Institute for Biomedical Research for her postdoctoral research in autism.
Catia holds a PhD in Neuroscience from the Weill Cornell Medical College, New York and the University of Lisbon, where she researched the molecular mechanisms of neuropsychiatric disorders. Catia has authored and co-authored several publications in the field of neuroscience, cardiology and oncology. She is currently enrolled in a MSc in Epidemiology at the London School of Hygiene and Tropical Medicine.